Biofrontera Inc. Depreciation
Biofrontera Inc. (BFRI) reported Depreciation of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-13
- Biofrontera Inc. depreciation for the quarter ending 2026-06-30 was $0.00.
- Biofrontera Inc. depreciation for the quarter ending 2026-03-31 was $0.00.
- Biofrontera Inc. depreciation for the quarter ending 2025-12-31 was $36.00K, a 5.26% decline year-over-year.
- Biofrontera Inc. depreciation for the quarter ending 2025-09-30 was $64.00K, a 220.00% increase year-over-year.
- Biofrontera Inc. depreciation for fiscal 2025 was $100.00K, a 0.00% change from fiscal 2024.
- Biofrontera Inc. depreciation for fiscal 2024 was $100.00K, a 16.28% increase from fiscal 2023.
- Biofrontera Inc. depreciation for fiscal 2023 was $86.00K, a 14.85% decline from fiscal 2022.
- Biofrontera Inc. depreciation for fiscal 2022 was $101.00K.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $36.00K derived: sum of 3 quarters · filed 2026-08-13 | $100.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | $36.00K derived: sum of 2 quarters · filed 2026-05-14 | $100.00K derived: sum of 3 quarters · filed 2026-05-14 | $100.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $100.00K derived: sum of 2 quarters · filed 2026-03-19 | $100.00K derived: sum of 3 quarters · filed 2026-08-13 | $100.00K 10-K · filed 2026-03-19 | |||
| 2025-09-30 | $64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $64.00K derived: sum of 2 quarters · filed 2026-08-13 | $64.00K 10-Q · filed 2025-11-12 | $102.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $47.00K 10-Q · filed 2025-08-13 | $38.00K derived: sum of 3 quarters · filed 2026-08-13 | $58.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | $25.00K 10-Q · filed 2025-05-15 | $38.00K derived: sum of 2 quarters · filed 2026-05-14 | $58.00K derived: sum of 3 quarters · filed 2026-05-14 | $79.00K derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2024-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $58.00K derived: sum of 2 quarters · filed 2026-03-19 | $79.00K derived: sum of 3 quarters · filed 2026-03-19 | $100.00K 10-K · filed 2026-03-19 | $92.00K 10-K · filed 2025-03-20 | ||
| 2024-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $41.00K derived: sum of 2 quarters · filed 2025-11-12 | $62.00K 10-Q · filed 2025-11-12 | $83.00K derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $42.00K 10-Q · filed 2025-08-13 | $63.00K derived: sum of 3 quarters · filed 2025-08-13 | $84.00K derived: sum of 4 quarters · filed 2025-08-13 | |||
| 2024-03-31 | $21.00K 10-Q · filed 2025-05-15 | $42.00K derived: sum of 2 quarters · filed 2025-05-15 | $63.00K derived: sum of 3 quarters · filed 2025-05-15 | $85.00K derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $42.00K derived: sum of 2 quarters · filed 2025-03-20 | $64.00K derived: sum of 3 quarters · filed 2025-03-20 | $86.00K 10-K · filed 2025-03-20 | |||
| 2023-09-30 | $21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $43.00K derived: sum of 2 quarters · filed 2024-11-14 | $65.00K 10-Q · filed 2024-11-14 | $86.00K derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | $22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $44.00K 10-Q · filed 2024-08-14 | $65.00K derived: sum of 3 quarters · filed 2024-08-14 | $91.00K derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | $22.00K 10-Q · filed 2024-05-15 | $43.00K derived: sum of 2 quarters · filed 2024-05-15 | $69.00K derived: sum of 3 quarters · filed 2024-05-15 | $95.00K derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $47.00K derived: sum of 2 quarters · filed 2024-03-15 | $73.00K derived: sum of 3 quarters · filed 2024-03-15 | $101.00K 10-K · filed 2024-03-15 | |||
| 2022-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $52.00K derived: sum of 2 quarters · filed 2023-11-09 | $80.00K 10-Q · filed 2023-11-09 | $105.00K derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | $26.00K 10-Q · filed 2022-08-12 | $54.00K 10-Q · filed 2023-08-11 | $79.00K derived: sum of 3 quarters · filed 2023-10-03 | $108.00K derived: sum of 4 quarters · filed 2023-10-03 | |||
| 2022-03-31 | $26.00K 10-Q · filed 2023-05-12 | $53.00K derived: sum of 2 quarters · filed 2023-10-03 | $82.00K derived: sum of 3 quarters · filed 2023-10-03 | $115.00K derived: sum of 4 quarters · filed 2023-10-03 | |||
| 2021-12-31 | $27.00K derived: 8-K 12 month − 10-Q 9 month · filed 2023-10-03 | $56.00K derived: sum of 2 quarters · filed 2023-10-03 | $89.00K derived: sum of 3 quarters · filed 2023-10-03 | $122.00K 8-K · filed 2023-10-03 | |||
| 2021-09-30 | $29.00K 10-Q · filed 2021-11-30 | $62.00K derived: sum of 2 quarters · filed 2022-08-12 | $95.00K 10-Q · filed 2022-11-14 | $130.00K derived: sum of 4 quarters · filed 2022-08-12 | |||
| 2021-06-30 | $33.00K 10-Q · filed 2022-08-12 | $66.00K 10-Q · filed 2022-08-12 | $101.00K derived: sum of 3 quarters · filed 2022-08-12 | $137.00K derived: sum of 4 quarters · filed 2022-08-12 | |||
| 2021-03-31 | $33.00K 10-Q · filed 2022-05-13 | $68.00K derived: sum of 2 quarters · filed 2022-05-13 | $104.00K derived: sum of 3 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-11 | $71.00K derived: sum of 2 quarters · filed 2022-04-11 | $144.00K 10-K · filed 2022-04-11 | ||||
| 2020-09-30 | $36.00K 10-Q · filed 2021-11-30 | $109.00K 10-Q · filed 2021-11-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |